The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coli
Abstract
An expression system was developed that allows the production of a completely functional antigen-binding fragment of an antibody in Escherichia coli . The variable domains of the phosphorylcholine-binding antibody McPC603 were secreted together into the periplasmic space, where protein folding as well as heterodimer association occurred correctly. Thus, the assembly pathway for the F v fragment in E. coli is similar to that of a whole antibody in the eukaryotic cell. The F v fragment of McPC603 was purified to homogeneity with an antigen-affinity column in a single step. The correct processing of both signal sequences was confirmed by amino-terminal protein sequencing. The functionality of the recombinant F v fragment was demonstrated by equilibrium dialysis. These experiments showed that the affinity constant of the F v fragment is identical to that of the native antibody McPC603, that there is one binding site for phosphorylcholine in the F v fragment, and that there is no inactive protein in the preparation. This expression system should facilitate future protein engineering experiments on antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Fling, S. P., & Gregerson, D. S. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90228-9 · Cited by 934
Molecular Architecture and \nBiological Reactions
Pauling, L. C. (1946) · CaltechAUTHORS (California Institute of Technology) · Cited by 865
Three-Dimensional Structure of Immunoglobulins
Amzel, L. M., & Poljak, R. J. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.004525 · Cited by 692
Selective Chemical Catalysis by an Antibody
Pollack, S. J., Jacobs, J. W., & Schultz, P. G. (1986) · Science · doi:10.1126/science.3787262 · Cited by 631
Tramontano, A., Janda, K. D., & Lerner, R. A. (1986) · Science · doi:10.1126/science.3787261 · Cited by 605
Segal, D. M., Padlan, E. A., Cohen, G. H., Rudikoff, S., Potter, M., & Davies, D. R. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.11.4298 · Cited by 466
Structural Basis of Antibody Function
Davies, D. R., & Metzger, H. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.000511 · Cited by 369
Cited by
Making antibodies by phage display technology
Winter, G., Griffiths, A. D., Hawkins, R. E., & Hoogenboom, H. R. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002245 · Cited by 1,573
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P., & Winter, G. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4133 · Cited by 1,020
Ward, E. S., Güssow, D., Griffiths, A. D., Jones, P. T., & Winter, G. (1989) · Nature · doi:10.1038/341544a0 · Cited by 1,003
Winter, G., & Milstein, C. (1991) · Nature · doi:10.1038/349293a0 · Cited by 945
Assessment of the Evolution of Cancer Treatment Therapies
Arruebo, M., Vilaboa, N., Sáez-Gutierrez, B., Lambea, J., Tres, A., Valladares, M., & González-Fernández, Á. (2011) · Cancers · doi:10.3390/cancers3033279 · Cited by 931
"Diabodies": small bivalent and bispecific antibody fragments.
Holliger, P., Prospero, T., & Winter, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6444 · Cited by 874
Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda
Huse, W. D., Sastry, L., Iverson, S. A., Kang, A. S., Alting-Mees, M., Burton, D. R., Benkovic, S. J., & Lerner, R. A. (1989) · Science · doi:10.1126/science.2531466 · Cited by 805
Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies
Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., & Muyldermans, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01062-4 · Cited by 768
scFv Antibody: Principles and Clinical Application
Ahmad, Z. A., Yeap, S. K., Ali, A. M., Ho, W. Y., Alitheen, N. B. M., & Hamid, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/980250 · Cited by 760
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
Orlandi, R., Güssow, D. H., Jones, P. T., & Winter, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3833 · Cited by 706
In vitro folding of inclusion body proteins
Rudolph, R., & Lilie, H. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.1.8566547 · Cited by 661
Single‐domain antibody fragments with high conformational stability
Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L. G. J., Muyldermans, S., Wyns, L., & Matagne, A. (2002) · Protein Science · doi:10.1110/ps.34602 · Cited by 638
Stability engineering of antibody single-chain Fv fragments
Wörn, A., & Plückthun, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4265 · Cited by 616
Self-citationDesigned Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
Plückthun, A. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134654 · Cited by 575
Self-citationSingle domain camel antibodies: current status
Muyldermans, S. (2001) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00021-6 · Cited by 552
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
Brekke, O. H., & Sandlie, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd984 · Cited by 550
Beyond natural antibodies: the power of in vitro display technologies
Bradbury, A. R. M., Sidhu, S., Dübel, S., & McCafferty, J. (2011) · Nature Biotechnology · doi:10.1038/nbt.1791 · Cited by 545
de Haard, H. J., van Neer, N., Reurs, A., Hufton, S. E., Roovers, R. C., Henderikx, P., de Bruı̈ne, A. P., Arends, J.-W., & Hoogenboom, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18218 · Cited by 533
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
Desmyter, A., Transue, T. R., Ghahroudi, M. A., Dao Thi, M.-H., Poortmans, F., Hamers, R., Muyldermans, S., & Wyns, L. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0996-803 · Cited by 522
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
A robust pipeline for rapid production of versatile nanobody repertoires
Fridy, P. C., Li, Y., Keegan, S., Thompson, M. K., Nudelman, I., Scheid, J. F., Oeffinger, M., Nussenzweig, M. C., Fenyö, D., Chait, B. T., et al. (2014) · Nature Methods · doi:10.1038/nmeth.3170 · Cited by 499
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies
Lauwereys, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3512 · Cited by 490
A comparison of strategies to stabilize immunoglobulin Fv-fragments
Glockshuber, R., Malia, M., Pfitzinger, I., & Plueckthun, A. (1990) · Biochemistry · doi:10.1021/bi00458a002 · Cited by 473
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 467
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Yin, H., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461786 · Cited by 453
Production of Soluble Recombinant Proteins in Bacteria
Schein, C. H. (1989) · Nature Biotechnology · doi:10.1038/nbt1189-1141 · Cited by 430
Hoogenboom, H. R., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90894-p · Cited by 429
Kang, A. S., Barbas, C. F., Janda, K. D., Benkovic, S. J., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4363 · Cited by 411
Antibodies and antibody-derived analytical biosensors
Sharma, S., Byrne, H., & O'Kennedy, R. J. (2016) · Essays in Biochemistry · doi:10.1042/ebc20150002 · Cited by 396
Efficient Cancer Therapy with a Nanobody-Based Conjugate
Cortez-Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., De Baetselier, P., Muyldermans, S., & Revets, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3935 · Cited by 382
On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5
Novotny, J., Bruccoleri, R. E., & Saul, F. A. (1989) · Biochemistry · doi:10.1021/bi00437a034 · Cited by 365
Expression of Recombinant Antibodies
Frenzel, A., Hust, M., & Schirrmann, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00217 · Cited by 353
Phage display technology: clinical applications and recent innovations
Azzazy, H. M. E., & Highsmith, W. E. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00343-0 · Cited by 351
Therapeutic antibody fragments with prolonged in vivo half-lives
Chapman, A. P., Antoniw, P., Spitali, M., West, S., Stephens, S., & King, D. J. (1999) · Nature Biotechnology · doi:10.1038/11717 · Cited by 350
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
Conrath, K. E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J.-M., Kinne, J., Wyns, L., & Muyldermans, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2807-2812.2001 · Cited by 347
Phage display-derived human antibodies in clinical development and therapy
Frenzel, A., Schirrmann, T., & Hust, M. (2016) · mAbs · doi:10.1080/19420862.2016.1212149 · Cited by 346
High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment
Carter, P., Kelley, R. F., Rodrigues, M. L., Snedecor, B., Covarrubias, M., Velligan, M. D., Wong, W. L. T., Rowland, A. M., Kotts, C. E., Carver, M. E., et al. (1992) · Nature Biotechnology · doi:10.1038/nbt0292-163 · Cited by 330
New protein engineering approaches to multivalent and bispecific antibody fragments
Plückthun, A., & Pack, P. (1997) · Immunotechnology · doi:10.1016/s1380-2933(97)00067-5 · Cited by 322
Self-citationTumour targeting with radiolabelled macrocycle–antibody conjugates
Parker, D. (1990) · Chem. Soc. Rev. · doi:10.1039/cs9901900271 · Cited by 319
A human recombinant haemoglobin designed for use as a blood substitute
Looker, D., Abbott-Brown, D., Cozart, P., Durfee, S., Hoffman, S., Mathews, A. J., Miller-Roehrkh, J., Shoemaker, S., Trimble, S., Fermi, G., et al. (1992) · Nature · doi:10.1038/356258a0 · Cited by 316
Antibody production, design and use for biosensor-based applications
Conroy, P. J., Hearty, S., Leonard, P., & O’Kennedy, R. J. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.010 · Cited by 314
Gram, H., Marconi, L. A., Barbas, C. F., Collet, T. A., Lerner, R. A., & Kang, A. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3576 · Cited by 307
Development trends for therapeutic antibody fragments
Nelson, A. L., & Reichert, J. M. (2009) · Nature Biotechnology · doi:10.1038/nbt0409-331 · Cited by 305
Coppieters, K., Dreier, T., Silence, K., Haard, H. D., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Wiele, C. V. D., Staelens, L., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21827 · Cited by 303
Els Conrath, K., Lauwereys, M., Wyns, L., & Muyldermans, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007734200 · Cited by 300
Recombinant Toxins for Cancer Treatment
Pastan, I., & FitzGerald, D. (1991) · Science · doi:10.1126/science.1683495 · Cited by 299
Pack, P., & Plueckthun, A. (1992) · Biochemistry · doi:10.1021/bi00121a001 · Cited by 291
Röthlisberger, D., Honegger, A., & Plückthun, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.01.053 · Cited by 289
Self-citationMcCormick, A. A., Kumagai, M. H., Hanley, K., Turpen, T. H., Hakim, I., Grill, L. K., Tusé, D., Levy, S., & Levy, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.703 · Cited by 275
Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems
Verma, R., Boleti, E., & George, A. J. T. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00077-5 · Cited by 265
Selection of human antibody fragments by phage display
Lee, C. M. Y., Iorno, N., Sierro, F., & Christ, D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.448 · Cited by 262
Levy, R., Weiss, R., Chen, G., Iverson, B. L., & Georgiou, G. (2001) · Protein Expression and Purification · doi:10.1006/prep.2001.1520 · Cited by 207
Principles for computational design of binding antibodies
Baran, D., Pszolla, M. G., Lapidoth, G. D., Norn, C., Dym, O., Unger, T., Albeck, S., Tyka, M. D., & Fleishman, S. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707171114 · Cited by 136
Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria
Robinson, M.-P., Ke, N., Lobstein, J., Peterson, C., Szkodny, A., Mansell, T. J., Tuckey, C., Riggs, P. D., Colussi, P. A., Noren, C. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9072 · Cited by 131
KORTT, A. A., MALBY, R. L., CALDWELL, J. B., GRUEN, L. C., IVANCIC, N., LAWRENCE, M. C., HOWLETT, G. J., WEBSTER, R. G., HUDSON, P. J., & COLMAN, P. M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18724.x · Cited by 128
Gąciarz, A., Khatri, N. K., Velez-Suberbie, M. L., Saaranen, M. J., Uchida, Y., Keshavarz-Moore, E., & Ruddock, L. W. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0721-x · Cited by 99
The rate-limiting steps for the folding of an antibody scFv fragment
Jäger, M., & Plückthun, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01350-1 · Cited by 44
Self-citationWeatherill, E. E., Cain, K. L., Heywood, S. P., Compson, J. E., Heads, J. T., Adams, R., & Humphreys, D. P. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs021 · Cited by 42
Ellis, M., Patel, P., Edon, M., Ramage, W., Dickinson, R., & Humphreys, D. P. (2017) · Biotechnology Progress · doi:10.1002/btpr.2393 · Cited by 34
Sina, M., Farajzadeh, D., & Dastmalchi, S. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.062 · Cited by 26
Metadata
- Authors
- Skerra, A., & Plückthun, A.
- Venue
- Science
- Published
- 1988-05-20
- Volume
- 240
- Issue
- 4855
- Pages
- 1038-1041
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2054592480
- Cited by
- 978
- References
- 27
- FWCI
- 47.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.